PDGFRA-IN-1
PDGFRA-IN-1 (Compound 4p) is a Platelet-derived growth factor receptor A (PDGFRA) inhibitor with an IC50 of 1.25 μM. PDGFRA-IN-1 has a significant anticancer activity and potently kills cancer cells including primary patient-derived glioma cells[1].
Product Specifications
UNSPSC
12352005
Target
PDGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C1C2=C(NC3=NC4=CC=CC=C4N3C2C5=C(C)N=CN5)CC(C6=CC=CC=C6)C1
Molecular Formula
C24H21N5O
Molecular Weight
395.46
References & Citations
[1]Parmar MP, et al. Ethanol-mediated one-pot synthesis of 3-phenyl-3,4,5,12-tetrahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1 (2H) -ones as PDGFRA inhibitors. Eur J Med Chem. 2025 Jul 4;297:117914.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-175212/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDGFRα
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IRBAHUMT-CYBAP373120UL 120 µL
Rabbit Anti Human MT-CYB Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4) (IHC,ELISA) 120ul
Ask
View Details 
GTR15151502 1 Vial
Lentiviral human USP13 shRNA (UAS) - Lentiviral human USP13 shRNA (UAS, iRFP) (25)
Ask
View Details 